Cleverbridge
30.11.2023 15:02:28 CET | ACCESS Newswire | Press release
The product's easy-to-use dashboards empower companies to accurately benchmark and forecast performance, calculate robust customer health scores, and more.
COLOGNE, GERMANY / ACCESSWIRE / November 30, 2023 / Cleverbridge, a growth engine for global technology companies, today announced the launch of CleverInsights, an advanced analytics suite that leverages AI and 18+ years of eCommerce data to provide unparalleled visibility into recurring revenue, retention, and other essential subscription metrics.
Pre-built dashboards for benchmarking, forecasting, anomaly detection, and customer health scoring empower organizations to derive deep insights and optimize performance in near real-time amid an uncertain and ever-changing business environment. These features streamline the reporting process and eliminate the burden of manual and time-consuming analysis, allowing employees to focus on more complex or strategic tasks when most companies are struggling to do more with less.
"As a CEO, I know firsthand how important it is to have accurate reporting. I also know that analysis is resource-intensive, and that too often resulting information is inaccurate, stale, or communicated without the context of broader industry or macroeconomic trends," said Wendi Sturgis, Chief Executive Officer of Cleverbridge. "With CleverInsights, any organization can reliably monitor and optimize recurring revenue with insights that are truly actionable. This grants a distinct competitive advantage, empowers data-driven decision making, and further enables technology companies to grow without adding headcount."
CleverInsights addresses a critical business need with benchmarking and forecasting, two capabilities that help companies interpret and predict key figures tied to recurring revenue with industry-leading levels of accuracy. Organizations can leverage these insights as needed to narrow their strategic focus while other areas of the product run continuously in the background. Anomaly detection, for instance, identifies unexpected changes in key metrics and alerts users to fluctuations along with the probable root causes for spikes or dips, allowing organizations to take immediate action and correct potential issues.
The product's robust customer health scores are calculated with standard inputs along with transaction data such as payment date, payment method, and expansion percentage. These additional data points strengthen the accuracy of health scores and feed into renewal and expansion propensity models that facilitate the effective prioritization of accounts. CleverInsights then recommends the best course of action for each customer, giving organizations the option to trigger automated or semi-automated interventions by leveraging another new Cleverbridge product, CleverAutomations.
General availability of CleverInsights is expected early next year. For more information and to schedule a demo, please visit grow.cleverbridge.com/products/cleverinsights.
About Cleverbridge
Cleverbridge makes it easy to maximize customer lifetime value. We leverage deep eCommerce expertise to orchestrate and automate frictionless self-service transactions across the entire customer journey, empowering customers to purchase, renew, and expand subscriptions in 248 countries and territories globally. For more than 18 years, our Growth Engine has integrated payments with subscription management, lifecycle marketing automation, advanced analytics, and partner ecosystems to consistently deliver recurring revenue growth without added headcount. Learn more at grow.cleverbridge.com.
Contact Information
Gordon Knapp
Senior Director, Marketing
gordon.knapp@cleverbridge.com
+17573458523
SOURCE: Cleverbridge
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/811741/cleverbridge-launches-cleverinsights-to-deliver-accurate-ai-powered-analytics-for-subscription-businesses
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
LiberNovo Previews Treat Yourself Halloween Flash Sale Across Europe29.10.2026 08:40:00 CET | Press release
HONG KONG, HK / ACCESS Newswire / October 29, 2026 / LiberNovo is bringing Halloween treats to the desk with its Treat Yourself Halloween Flash Sale, opening October 29 across the European Union and United Kingdom. The event pairs savings of up to 40% on selected Maxis and LiberNovo Omni Pro configurations with limited seasonal gifts for qualifying early shoppers. Spooky extras for your desk Limited Halloween-themed gift packs are available to the first 300 eligible customers in the European Union and the first 100 in the United Kingdom, on a first-come, first-served basis while supplies last. Gift contents, qualifying purchases and availability follow the terms on each regional campaign page. More room for Big and Tall users Maxis is designed around larger frames, with a wider seat and 52 cm seat depth for greater thigh support and room to shift naturally. Maxis Manual provides adjustment by hand. Maxis Electric adds motorised lumbar adjustment and OmniStretch guided back stretching.
IAVI Awarded $36 Million From BARDA for Bundibugyo Virus Vaccine Development28.10.2026 16:50:00 CET | Press release
NEW YORK, NY, SINGAPORE, SG INCHEON, SOUTH KOREA, AND DESSAU-ROSSLAU, DE / ACCESS Newswire / October 28, 2026 / Today IAVI, a global nonprofit biomedical research organization, together with partners Hilleman Laboratories, SK bioscience, and IDT Biologika announced that IAVI has been awarded US $36 million of a contract valued up to US $99 million from the Administration for Strategic Preparedness and Response (ASPR); Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, to advance development, manufacturing, and clinical evaluation of its one-dose vaccine candidate against Bundibugyo virus (BDBV), the cause of the ongoing Ebola epidemic in the Democratic Republic of the Congo (DRC). The award supports manufacturing of vaccine doses for clinical evaluation and outbreak response, clinical and regulatory activities including a Phase 1 trial, and options for expanded manufacturing to support future preparedness needs, as
GA-ASI and Saab Perform Advanced AEW Flight Testing on Uncrewed MQ-9B28.10.2026 16:00:00 CET | Press release
SAN DIEGO, CA / ACCESS Newswire / October 28, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) has partnered with Saab to perform advanced flight testing of an Airborne Early Warning (AEW) system on an Uncrewed Aircraft System (UAS). The flight testing was conducted over the past few months using a GA-ASI-produced MQ-9B carrying a Saab LoyalEye radar operating from GA-ASI's Desert Horizon flight operations facility in Southern California. The flight test demonstrated simultaneous tracking of several airborne and maritime targets at long ranges. The airborne targets tracked included multiple instrumented red fighter jets and several commercial aircraft. MQ-9B is GA-ASI's flagship UAS, offering unmatched endurance, type certification and all-weather performance. GA-ASI is discussing unmanned AEW capabilities on MQ-9B with several customers. "This has been one of the most highly anticipated flight tests we have performed," said GA-ASI President David R. Alexander. "The level of
Juno Corp. Closes $25 Million Non-Brokered Private Placement28.10.2026 12:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / October 28, 2026 / Juno Corp. ("Juno" or the "Company"), the largest mineral claim holder and most active explorer in Ontario's Ring of Fire, is pleased to announce that it has completed a non-brokered private placement (the "Offering") for aggregate gross proceeds of $25,290,609. Pursuant to the Offering, the Company issued an aggregate of (i) 165,750 common shares of Juno ("HD Juno Shares"), on a non-flow-through basis at a price of $4.00 per HD Juno Share, (ii) 404,890 common shares of Juno that qualify as "flow-through shares" as defined in subsection 66(15) of the Income Tax Act (Canada) (the "Tax Act") (the "FT Juno Shares"), at a price of $4.50 per FT Juno Share, and (iii) 4,131,450 common shares of Juno, which qualify as "flow-through shares" as defined in subsection 66(15) of the Tax Act (the "Premium FT Juno Shares", and together with the HD Juno Shares and the FT Juno Shares, the "Juno Securities"), at a price of $5.52 per Premium FT Juno Shar
DistillerSR Launches Smart Chat, an AI Chat Interface Built Into Its Evidence Platform27.10.2026 15:55:00 CET | Press release
OTTAWA, ON / ACCESS Newswire / October 27, 2026 / DistillerSR® Inc., the pioneer and market leader in AI-enabled literature review automation and evidence management, today announced the launch of Smart Chat. Smart Chat brings DistillerSR's Agentic AI capabilities in-platform. Since September 2025, DistillerSR Agentic AI has eliminated evidence silos at customer organizations by connecting Large Language Models to a repository of expertly validated literature evidence. Smart Chat now makes that same capability available natively within DistillerSR's secure platform. "While researchers recognize the power of generative AI, many life sciences organizations cannot risk connecting external LLMs to their sensitive research data," said Peter O'Blenis, CEO of DistillerSR. "Smart Chat removes that barrier. It is built directly into the platform teams already use, works exclusively with their own DistillerSR projects, and is included with every version of DistillerSR." Smart Chat works only wit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom